Tempest Therapeutics Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$1.11

+0.01 (+0.91%)

As of Jun 30, 10:52 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 6 86%

Hold 1 14%

Sell 0 0%

Price Target

Analyst Price Target +3,838.7% upside

Low Target $35.70

Average Target $43.72

High Target $58.20

Current Price $1.11

Current
$1.11

Target
$43.72

$35.70 $43.72 avg $58.20

Scenario Analysis

Bear Case

$35.70

3,116.2%

Low target

Base Case

$43.72

+3,838.7%

Avg target

Bull Case

$58.20

+5,143.2%

High target

Risk/Reward

1.7x

Balanced

Price in Context

52-Week High

$12.23

-90.9% from high

52-Week Low

$1.02

+8.8% from low

Target vs 52W High

$43.72

+257.5% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+2.4%
AMGN Amgen Inc	Hold	44	50%	$190.87	-47.3%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+187.1%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-11.8%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.7%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-66.0%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-39.1%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-47.4%